| 000 | 01647 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516181713.0 | ||
| 264 | 0 | _c20140911 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1096-0023 | ||
| 024 | 7 |
_a10.1016/j.cyto.2013.10.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarvey, B S | |
| 245 | 0 | 0 |
_aInterleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. _h[electronic resource] |
| 260 |
_bCytokine _cFeb 2014 |
||
| 300 |
_a236-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aArachidonic Acids _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aCannabidiol _xpharmacology |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 | _aElectric Impedance |
| 650 | 0 | 4 |
_aEndocannabinoids _xpharmacology |
| 650 | 0 | 4 |
_aEpithelial Cells _xdrug effects |
| 650 | 0 | 4 |
_aEpithelium _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterleukin-17 _xadverse effects |
| 650 | 0 | 4 |
_aInterleukin-1beta _xpharmacology |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aPolyunsaturated Alkamides _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aSia, T C | |
| 700 | 1 | _aWattchow, D A | |
| 700 | 1 | _aSmid, S D | |
| 773 | 0 |
_tCytokine _gvol. 65 _gno. 2 _gp. 236-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cyto.2013.10.006 _zAvailable from publisher's website |
| 999 |
_c23272800 _d23272800 |
||